Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Axogen Inc

Current price
7.15 USD -0.26 USD (-3.51%)
Last closed 7.41 USD
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 312 487 904 USD
Yield for 12 month -21.43 %
21.11.2021 - 28.11.2021

AxoGen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments; and Axoguard HA+ Nerve Protector, a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating designed to provide short- and long-term protection for peripheral nerve injuries. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and AxoTouch two-point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. AxoGen, Inc. is headquartered in Alachua, Florida. Address: 13631 Progress Boulevard, Alachua, FL, United States, 32615

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
MSFT MSFT Microsoft


WallStreet Target Price

12.67 USD

P/E ratio

Dividend Yield

Current Year

+159 012 000 USD

Last Year

+138 584 000 USD

Current Quarter

+41 378 000 USD

Last Quarter

+42 922 000 USD

Current Year

+127 874 000 USD

Last Year

+114 437 000 USD

Current Quarter

+32 620 000 USD

Last Quarter

+33 764 000 USD

Key Figures AXGN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -13 388 000 USD
Operating Margin TTM -11.02 %
PE Ratio
Return On Assets TTM -6.21 %
PEG Ratio
Return On Equity TTM -22.32 %
Wall Street Target Price 12.67 USD
Revenue TTM 163 726 000 USD
Book Value 2.13 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 12.9 %
Dividend Yield
Gross Profit TTM 114 437 000 USD
Earnings per share -0.49 USD
Diluted Eps TTM -0.49 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin -13 %

Dividend Analytics AXGN

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History AXGN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date 27.01.2010
Forward Annual Dividend Yield
Last Split Factor 105:100
Payout Ratio
Last Split Date 11.07.1994
Dividend Date 12.02.2010

Stock Valuation AXGN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 2.2229
Price Sales TTM 1.9809
Enterprise Value EBITDA -26.5212
Price Book MRQ 3.2949

Financials AXGN

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators AXGN

For 52 weeks

3.45 USD 10.83 USD
50 Day MA 6.66 USD
Shares Short Prior Month 1 858 543
200 Day MA 6.93 USD
Short Ratio 7.02
Shares Short 1 773 206
Short Percent 5.05 %

Dynamics of changes in the value of assets




446.34 USD Microsoft Corporation -3.37 (-0.75%)
Detailed analytics

ETF funds



203.95 CHF UBS SLI A-dis -0.06 (-0.02%)
Detailed analytics



2339.94 USD Gold +11.09 (+0.48%)
Detailed analytics